Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion.
Cabrero M, Yu Y, Verma A, Yang H, Colla S, Jia Y, Zheng H, Bohannan Z, Ganan-Gomez I, Futreal A, Takahashi K, Chin L, Kantarjian H, Pellagatti A, Bowman T, Boultwood J, Garcia-Manero G, Wei Y. Cabrero M, et al. Among authors: zheng h. Br J Haematol. 2016 Apr;173(1):161-5. doi: 10.1111/bjh.13574. Epub 2015 Jun 24. Br J Haematol. 2016. PMID: 26105212 Free PMC article. No abstract available.
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Ganan-Gomez I, Ebert B, Levine R, Kantarjian H, Garcia-Manero G. Wei Y, et al. Among authors: zheng h. Leukemia. 2013 Nov;27(11):2177-86. doi: 10.1038/leu.2013.91. Epub 2013 Mar 29. Leukemia. 2013. PMID: 23538751 Free PMC article.
Low frequency of H3.3 mutations and upregulated DAXX expression in MDS.
Attieh Y, Geng QR, Dinardo CD, Zheng H, Jia Y, Fang ZH, Gañán-Gómez I, Yang H, Wei Y, Kantarjian H, Garcia-Manero G. Attieh Y, et al. Among authors: zheng h. Blood. 2013 May 9;121(19):4009-11. doi: 10.1182/blood-2012-11-466714. Blood. 2013. PMID: 23660862 Free article. No abstract available.
Toll-like receptor alterations in myelodysplastic syndrome.
Wei Y, Dimicoli S, Bueso-Ramos C, Chen R, Yang H, Neuberg D, Pierce S, Jia Y, Zheng H, Wang H, Wang X, Nguyen M, Wang SA, Ebert B, Bejar R, Levine R, Abdel-Wahab O, Kleppe M, Ganan-Gomez I, Kantarjian H, Garcia-Manero G. Wei Y, et al. Among authors: zheng h. Leukemia. 2013 Sep;27(9):1832-40. doi: 10.1038/leu.2013.180. Epub 2013 Jun 14. Leukemia. 2013. PMID: 23765228 Free PMC article.
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Wei Y, Zheng H, Lockyer PP, Darbaniyan F, Li Z, Kanagal-Shamanna R, Soltysiak KA, Yang H, Ganan-Gomez I, Montalban-Bravo G, Chien KS, Do KA, Daver N, Garcia-Manero G. Wei Y, et al. Among authors: zheng h. Leuk Lymphoma. 2022 Dec;63(13):3154-3164. doi: 10.1080/10428194.2022.2116932. Epub 2022 Sep 5. Leuk Lymphoma. 2022. PMID: 36059252 Free PMC article.
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
Darbaniyan F, Zheng H, Kanagal-Shamanna R, Lockyer P, Montalban-Bravo G, Estecio M, Lu Y, Soltysiak KA, Chien KS, Yang H, Sasaki K, Class C, Ganan-Gomez I, Do KA, Garcia-Manero G, Wei Y. Darbaniyan F, et al. Among authors: zheng h. Exp Hematol. 2022 Nov;115:44-53. doi: 10.1016/j.exphem.2022.09.002. Epub 2022 Sep 21. Exp Hematol. 2022. PMID: 36150563 Free article.
Downregulation of UBA1 expression in myelodysplastic neoplasm.
Wei Y, Zheng H, Li Z, Lockyer PP, Darbaniyan F, Kanagal-Shamanna R, Yang H, Hammond D, Garcia-Manero G. Wei Y, et al. Among authors: zheng h. Leukemia. 2024 Oct;38(10):2284-2288. doi: 10.1038/s41375-024-02364-x. Epub 2024 Aug 23. Leukemia. 2024. PMID: 39179668 Free PMC article. No abstract available.
17,669 results
You have reached the last available page of results. Please see the User Guide for more information.